Compare fund portfolios
See how two funds' portfolios overlap. Enter two tickers:
HTEC vs GNOM
Shared holdings
14
HTEC covered by GNOM
22.81%
GNOM covered by HTEC
22.81%
Coverage = share of one portfolio's weight reproduced by the other (overlapping positions, min weight). Top 50 positions per side shown; = held by both — hover a shared position to highlight it in both columns.
HTEC (Jan. 31, 2026)
| Security | Weight | |
|---|---|---|
| MODERNA INC | 2.20% | |
| ARROWHEAD PHARMACEUTICALS INC | 2.18% | |
| GUARDANT HEALTH INC | 2.16% | |
| ADAPTIVE BIOTECHNOLOGIES CORP | 2.13% | |
| PENUMBRA INC | 2.12% | |
| AXOGEN INC | 2.02% | |
| ILLUMINA INC | 2.00% | |
| VERTEX PHARMACEUTICALS INC | 2.00% | |
| TWIST BIOSCIENCE CORP | 1.97% | |
| STRYKER CORP | 1.96% | |
| THERMO FISHER SCIENTIFIC INC | 1.95% | |
| EUROFINS SCIENTIFIC SE (BEARER) | 1.95% | |
| LivaNova PLC ORD GBP1.00 (DI) | 1.89% | |
| SIEMENS HEALTHINEERS AG COMMON STOCK | 1.88% | |
| BOSTON SCIENTIFIC CORP | 1.85% | |
| KONINKLIJKE PHIL | 1.85% | |
| REGENERON PHARMACEUTICALS INC | 1.84% | |
| NATERA INC | 1.83% | |
| NOVANTA INC | 1.82% | |
| IQVIA HOLDINGS INC | 1.80% | |
| LONZA GROUP -REG | 1.78% | |
| ROCHE HOLDINGS AG (GENUSSCHEINE) | 1.75% | |
| CHARLES RIVER LABS INTL INC | 1.73% | |
| QIAGEN NV ORD SHARES | 1.72% | |
| MEDPACE HOLDINGS INC | 1.71% | |
| GLAUKOS CORP | 1.70% | |
| INTUITIVE SURGICAL INC | 1.69% | |
| JD HEALTH INTERN | 1.69% | |
| EXACT SCIENCES CORP | 1.68% | |
| NOVOCURE LTD | 1.66% | |
| GLOBUS MEDICAL INC | 1.66% | |
| GRAIL INC | 1.65% | |
| DANAHER CORP | 1.65% | |
| CAREDX INC | 1.63% | |
| INCYTE CORP | 1.62% | |
| TECAN GROUP AG-R | 1.62% | |
| DIASORIN SPA COMMON STOCK | 1.60% | |
| EDWARDS LIFESCIENCES CORP COMMON STOCK | 1.58% | |
| ARTIVION INC | 1.56% | |
| BECTON DICKINSON AND CO COMMON STOCK | 1.50% | |
| BRISTOL-MYERS SQUIBB CO | 1.50% | |
| ABBOTT LABORATORIES COMMON STOCK | 1.45% | |
| TEMPUS AI INC-A | 1.45% | |
| ALNYLAM PHARMACEUTICALS INC | 1.43% | |
| GE HEALTHCARE TECHNOLOGIES INC WI | 1.42% | |
| BIOMARIN PHARMACEUTICAL INC | 1.41% | |
| AGILENT TECHNOLOGIES INC | 1.38% | |
| OMNICELL INC | 1.37% | |
| IRHYTHM TECHNOLOGIES INC | 1.37% | |
| BIO-RAD LABORATORIES-A COMMON STOCK | 1.36% |
GNOM (Feb. 28, 2026)
| Security | Weight | |
|---|---|---|
| MODERNA INC | 7.68% | |
| PRAXIS PRECISION MEDICINES INC | 6.09% | |
| ARROWHEAD PHARMACEUTICALS INC | 5.56% | |
| ILLUMINA INC | 5.01% | |
| GUARDANT HEALTH INC | 4.60% | |
| VERTEX PHARMACEUTICALS INC | 4.22% | |
| BIOMARIN PHARMACEUTICAL INC | 4.21% | |
| NATERA INC | 3.82% | |
| BIONTECH SE ADR | 3.78% | |
| AVIDITY BIOSCIENCES | 3.66% | |
| QIAGEN NV ORD SHARES | 3.55% | |
| CRISPR Therapeutics A.G. Series A | 3.40% | |
| BIO-TECHNE CORP | 3.37% | |
| BRISTOL-MYERS SQUIBB CO | 2.59% | |
| ALNYLAM PHARMACEUTICALS INC | 2.45% | |
| BNYREPOS | 2.34% | |
| VERACYTE INC | 2.33% | |
| LILLY ELI and CO | 2.29% | |
| TWIST BIOSCIENCE CORP | 2.24% | |
| GILEAD SCIENCES INC | 2.23% | |
| ASTRAZENECA PLC | 2.22% | |
| BEAM THERAPEUTICS INC | 2.16% | |
| 10X GENOMICS INC | 2.11% | |
| LEGEND BIOTECH CORP SPON ADR | 2.09% | |
| ULTRAGENYX PHARMA INC | 1.74% | |
| GENEDX HOLDINGS CORP-A | 1.68% | |
| Wave Life Sciences Ltd. COM NPV | 1.47% | |
| GENSCRIPT BIOTEC | 1.42% | |
| SAREPTA THERAPEUTICS INC | 1.28% | |
| INTELLIA THERAPEUTICS INC | 1.16% | |
| CAREDX INC | 0.78% | |
| UNIQURE NV COMMON STOCK EUR.05 | 0.71% | |
| VIR BIOTECHNOLOGY INC | 0.68% | |
| PERSONALIS INC | 0.40% | |
| PACIFIC BIOSCIENES OF CALI INC | 0.37% | |
| AGILENT TECHNOLOGIES INC | 0.37% | |
| ROCKET PHARMACEUTICALS INC | 0.35% | |
| PRIME MEDICINE INC | 0.35% | |
| REGENXBIO INC | 0.35% | |
| MYRIAD GENETICS INC | 0.34% | |
| MESA LABS | 0.33% | |
| MARAVAI LIFESCIENCES HOLDINGS INC | 0.31% | |
| STOKE THERAPEUTICS INC | 0.31% | |
| STANDARD BIOTOOLS INC | 0.25% | |
| FULGENT GENETICS INC | 0.25% | |
| ARCTURUS THERAPEUTICS HOLDINGS INC | 0.23% | |
| CARIBOU BIOSCIENCES INC | 0.21% | |
| SANA BIOTECHNOLOGY INC | 0.21% | |
| SANGAMO THERAPEUTICS INC | 0.20% | |
| EDITAS MEDICINE INC | 0.19% |
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.